CHEK1 and prostate cancer: Recently, Lunardi et al. showed transcriptional repression of Chk1 through oncogenic E26 transformation-specific (ETS) transcription factors in prostate cancer, which resulted in reduced Chk1 levels and unrepaired DNA damage [34].